Founded in 2020 under the dynamic and visionary leadership of Mr. Rakesh Sutariya, Zenovel has embarked on a remarkable journey to simplify regulatory complexities while upholding the highest standards of ethical integrity.
In just four years, we have established ourselves as a trusted partner in the healthcare and pharmaceutical sectors, setting new benchmarks of excellence through innovation and unwavering commitment. Our team, a powerhouse of expertise, combines over a decade of collective experience. This unique blend of industry veterans and forward-thinking professionals enables us to anticipate and adapt to emerging trends, helping our clients maintain a competitive edge.
Zenovel’s dedication to excellence and client success has fuelled our expansion across multiple nations, strengthening our global footprint. Our GMP support services, lauded by clients worldwide, exemplify our unwavering commitment to quality and reliability.
With an impressive track record of 332 successful audits for prominent companies, we have consistently nurtured partnerships, built trust, and catalysed transformative growth for our clients. This dedication earned us the prestigious recognition as one ofIndia Pharma Outlook’s Top 10 Pharmaceutical Regulatory Consultants for 2024. This accolade underscores our leadership in the field and reinforces our position as the preferred partner for pharmaceutical and healthcare organizations globally.
At Zenovel, we take pride in our customer-centric approach. We have supported over 50 international clients in achieving their healthcare goals, offering tailored solutions to navigate regulatory landscapes, ensure compliance, and drive innovation.
As we expand our horizons, Zenovel remains steadfast in its commitment to fostering partnerships built on integrity, transparency, and quality. Together, we are shaping the future of pharmaceutical quality control and healthcare—one milestone at a time.
After reaching significant milestones in our journey so far, Zenovel looks forward to an even brighter and more impactful future. Our strategy is rooted in the belief that success is achieved in stages, with each action taken today laying the foundation for future accomplishments.
Pharmacovigilance (PV), the scientific process of detection, assessment, understanding, and prevention of adverse drug reactions, is going to be revolutionized in 2025. PV is evolving from a more reactive to a proactive discipline, aided by new and evolving technologies, including quantum-enhanced AI, global safety monitoring in real time, and other
In the world of globalized pharmaceutical industry, clinical trials and regulatory affairs are becoming ever more international in terms of languages and cultures. India is well on the way to becoming a global pharmaceutical hub in 2025, now is the time to ensure that we get accurate translation and localization
The Indian pharmaceutical industry, a global leader and the third-largest medicine producer by volume, is renowned for providing cost-effective, high-quality drugs worldwide. In 2025, new regulatory frameworks and stringent compliance requirements are being implemented, compelling Indian pharma companies to adapt. These reforms aim to enhance credibility, safety, and global competitiveness,
Steps to Optimize Your Regulatory Affairs Process Regulatory affairs professionals in medical technology are crucial in ensuring compliance and market entry. Such professionals face challenges in navigating registration processes, fostering collaboration, and utilizing data-driven insights. Innovative regulatory solutions can enhance efficiency and improve outcomes. This blog presents five transformative strategies
In the fast-paced and highly regulated world of pharmaceuticals and nutraceuticals, following Good Manufacturing Practices (GMP) is vital for assuring safety, quality, and regulatory compliance. Dealing with the intricacies of GMP standards can be overwhelming, requiring extensive technical knowledge and strategic assistance. A reliable GMP consultants can provide valuable assistance.
Drug discovery to market approval is a lengthy and arduous endeavor, lasting a year or more while taking an enormous amount of resources and finances. Among the various processes in going from discovery to market, Chemistry, Manufacturing, and Controls (CMC) is essential in establishing that drugs are safe and effective
